BACKGROUND: Mice sensitized to ovalbumin develop allergic airway disease (AAD) with short-term aerosol challenge; however, airway inflammation resolves with long-term aerosol challenge, referred to as local inhalational tolerance (LIT). METHODS: We sought to determine if resolution of airway inflammation correlated with increases in lymphocyte subsets in local lung compartments, including putative regulatory T cells. RESULTS: At the AAD stage, total numbers of T and B lymphocytes in bronchoalveolar lavage (BAL) were significantly increased above controls; however, at LIT, T and B lymphocytes were significantly reduced compared to AAD. In the lung tissue, the only alteration was a significant increase in CD4+ CD25+ T cells at AAD. In the hilar lymph node (HLN), CD4+ and CD4+ CD25+ T cells were significantly increased at AAD and LIT. In addition, CD8+ T cells were significantly elevated in the HLN at LIT, and CD19+ B cells were significantly increased at AAD. Adoptive transfer of HLN lymphocytes to lymphopenic mice confirmed that AAD lymphocytes could induce airway inflammation in response to aerosol challenge, whereas LIT lymphocytes were unable to do so. Depletion of CD4+ CD25+ T cells in vivo resulted in exacerbation of inflammation at AAD and LIT. CD4+ CD25+ T cells in the HLN also displayed suppressive activity in vitro. Additionally, T cells expressing Foxp3 were increased in the BAL and HLN during LIT. CONCLUSIONS: These results indicate that lymphocytes with regulatory functions are increased and sustained in local lung compartments at LIT and that their appearance correlates with the resolution of lung inflammation. 2007 S. Karger AG, Basel
BACKGROUND:Mice sensitized to ovalbumin develop allergic airway disease (AAD) with short-term aerosol challenge; however, airway inflammation resolves with long-term aerosol challenge, referred to as local inhalational tolerance (LIT). METHODS: We sought to determine if resolution of airway inflammation correlated with increases in lymphocyte subsets in local lung compartments, including putative regulatory T cells. RESULTS: At the AAD stage, total numbers of T and B lymphocytes in bronchoalveolar lavage (BAL) were significantly increased above controls; however, at LIT, T and B lymphocytes were significantly reduced compared to AAD. In the lung tissue, the only alteration was a significant increase in CD4+ CD25+ T cells at AAD. In the hilar lymph node (HLN), CD4+ and CD4+ CD25+ T cells were significantly increased at AAD and LIT. In addition, CD8+ T cells were significantly elevated in the HLN at LIT, and CD19+ B cells were significantly increased at AAD. Adoptive transfer of HLN lymphocytes to lymphopenicmice confirmed that AAD lymphocytes could induce airway inflammation in response to aerosol challenge, whereas LIT lymphocytes were unable to do so. Depletion of CD4+ CD25+ T cells in vivo resulted in exacerbation of inflammation at AAD and LIT. CD4+ CD25+ T cells in the HLN also displayed suppressive activity in vitro. Additionally, T cells expressing Foxp3 were increased in the BAL and HLN during LIT. CONCLUSIONS: These results indicate that lymphocytes with regulatory functions are increased and sustained in local lung compartments at LIT and that their appearance correlates with the resolution of lung inflammation. 2007 S. Karger AG, Basel
Authors: Wendy W J Unger; Wendy Jansen; Danielle A W Wolvers; Astrid G S van Halteren; Georg Kraal; Janneke N Samsom Journal: Int Immunol Date: 2003-06 Impact factor: 4.823
Authors: Omid Akbari; Gordon J Freeman; Everett H Meyer; Edward A Greenfield; Tammy T Chang; Arlene H Sharpe; Gerald Berry; Rosemarie H DeKruyff; Dale T Umetsu Journal: Nat Med Date: 2002-07-29 Impact factor: 53.440
Authors: Claudia Zuany-Amorim; Elzbieta Sawicka; Corinne Manlius; Alain Le Moine; Laura R Brunet; David M Kemeny; Gareth Bowen; Graham Rook; Christoph Walker Journal: Nat Med Date: 2002-06 Impact factor: 53.440
Authors: F K Swirski; B U Gajewska; D Alvarez; S A Ritz; M J Cundall; E C Cates; A J Coyle; J-C Gutierrez-Ramos; M D Inman; M Jordana; M R Stämpfli Journal: Clin Exp Allergy Date: 2002-03 Impact factor: 5.018
Authors: B U Gajewska; F K Swirski; D Alvarez; S A Ritz; S Goncharova; M Cundall; D P Snider; A J Coyle; J C Gutierrez-Ramos; M R Stämpfli; M Jordana Journal: Am J Respir Cell Mol Biol Date: 2001-09 Impact factor: 6.914
Authors: Filip K Swirski; Dusan Sajic; Clinton S Robbins; Beata U Gajewska; Manel Jordana; Martin R Stämpfli Journal: J Immunol Date: 2002-10-01 Impact factor: 5.422
Authors: Simon Fillatreau; Claire H Sweenie; Mandy J McGeachy; David Gray; Stephen M Anderton Journal: Nat Immunol Date: 2002-09-03 Impact factor: 25.606
Authors: Jeffrey T McNamara; Craig M Schramm; Anurag Singh; Eric R Secor; Linda A Guernsey; Leo Lefrançois; Roger S Thrall Journal: Am J Pathol Date: 2012-03-24 Impact factor: 4.307
Authors: Biree Andemariam; Alexander J Adami; Anurag Singh; Jeffrey T McNamara; Eric R Secor; Linda A Guernsey; Roger S Thrall Journal: Transl Res Date: 2015-03-16 Impact factor: 7.012
Authors: L Faustino; D M Fonseca; E B Florsheim; R R Resende; A P Lepique; E Faquim-Mauro; E Gomes; J S Silva; H Yagita; M Russo Journal: Mucosal Immunol Date: 2014-02-26 Impact factor: 7.313
Authors: Sonali J Bracken; Alexander J Adami; Steven M Szczepanek; Mohsin Ehsan; Prabitha Natarajan; Linda A Guernsey; Neda Shahriari; Ektor Rafti; Adam P Matson; Craig M Schramm; Roger S Thrall Journal: Int Arch Allergy Immunol Date: 2015-04-28 Impact factor: 2.749
Authors: Anurag Singh; Roger S Thrall; Linda A Guernsey; William F Carson; Eric R Secor; Robert E Cone; Thiruchandurai V Rajan; Craig M Schramm Journal: Immunol Cell Biol Date: 2008-05-06 Impact factor: 5.126
Authors: Anurag Singh; William F Carson; Eric R Secor; Linda A Guernsey; Richard A Flavell; Robert B Clark; Roger S Thrall; Craig M Schramm Journal: J Immunol Date: 2008-06-01 Impact factor: 5.422
Authors: P Natarajan; A Singh; J T McNamara; E R Secor; L A Guernsey; R S Thrall; C M Schramm Journal: Mucosal Immunol Date: 2012-06-20 Impact factor: 7.313